BBT GROUP LIMITED

Financial Health Score: C+

Explanation: BBT Group Limited is like a patient with a strong underlying constitution but is currently suffering from a chronic, slow bleed. While the company possesses a healthy cash reserve and zero immediate threat of insolvency, it has experienced significant and continuous erosion of its overall value over the last three years. The persistent operating losses are a symptom of an underlying issue that requires treatment before the reserves are depleted.

1. Key Vital Signs

Blood Pressure (Liquidity & Current Ratio) Current Assets (£3.32M) vs. Current Liabilities (£1.90M) The company's blood pressure is stable. With a current ratio of approximately 1.75, BBT Group has more than enough liquid assets to cover its short-term debts. The "blood flow" to creditors is healthy, meaning there is no immediate risk of a cardiac arrest (insolvency) or defaulting on immediate obligations.

Heartbeat (Cash Reserves) Cash at Bank: £2.31M (2024) vs. £2.58M (2023) The heartbeat remains strong, but the rhythm is slowing. The company still holds over £2.3 million in cash, which is an excellent defensive position. However, this is down from a peak of £7.3 million in 2021. The pulse is weakening year over year as cash is consumed to fund operations and pay liabilities.

Weight (Net Assets & Shareholders' Funds) Net Assets: £2.29M (2024) vs £2.76M (2023) The patient is losing weight at an alarming rate. Net assets have dropped by nearly half a million pounds in the last year alone. Looking at the broader history, the company's net worth has shrunk drastically from a peak of £7.51 million in 2021 to £2.29 million in 2024. This represents a nearly 70% loss of total body mass (equity) in just three years.

Cholesterol (Liabilities) Total Current Liabilities: £1.90M (2024) vs £1.78M (2023) There is a slight buildup of plaque. Current liabilities have ticked up, driven primarily by an increase in taxation/social security owed (£673k vs £595k) and other creditors (£1.12M vs £1.03M). While manageable right now, the growing "other creditors" category should be monitored to ensure it doesn't restrict arterial flow.

Muscle Mass (Fixed Assets) Tangible Assets: £871k (2024) The company retains strong muscle mass, primarily in the form of a freehold property valued at £852k. This provides a solid foundation and a potential asset to leverage if the patient needs a financial transfusion.

2. Diagnosis

Condition: Chronic Hemorrhaging of Retained Earnings

The financial data reveals that BBT Group Limited is suffering from persistent operational losses. Because the company files under the small companies regime, the Profit & Loss account is not disclosed, but the vital signs tell the story clearly: Retained earnings dropped from £2.76M to £2.29M in 2024, indicating a loss of approximately £472,000 for the year. This follows a pattern of massive losses stretching back to 2021, where retained earnings stood at £7.51 million.

In medical terms, the business is bleeding out its historical reserves. The "immunity" provided by the massive cash reserves built up prior to 2021 is fighting off the infection of current losses, but that immunity is depleting. The company is converting its cash reserves into operational funding to survive the current climate.

The nature of the business—life insurance, reinsurance, and pension funding (SIC codes 65110, 65201, 65300)—suggests that these losses could be related to market volatility, claims, or structural changes in their asset management portfolio (formerly Bebbington Brumby Asset Management). The good news is that the patient is still breathing comfortably due to a robust cash position; the bad news is that without intervention, the current rate of blood loss will eventually prove fatal.

3. Prognosis

Cautious to Concerning

The short-term prognosis is stable. With £2.31 million in cash and net current assets of £1.42 million, BBT Group will not face a liquidity crisis in the immediate future.

However, the long-term prognosis is concerning if the current trajectory continues. At the 2024 rate of cash consumption and equity loss, the company has a finite runway. If the business continues to hemorrhage roughly £470k in equity annually, it will severely compromise its financial health within 4-5 years. The transition from a £7.5M net worth company to a £2.3M net worth company in three years is a severe symptom that the underlying business model or market conditions have fundamentally shifted since 2021.

4. Recommendations

To restore the patient to full financial wellness, the following interventions are prescribed:

1. Triage the Cash Burn: Conduct an immediate, deep audit of operational expenses versus commission income. The bleeding must be stopped by identifying which areas of the business are operating at a loss and applying a tourniquet to unnecessary expenditures.
2. Investigate "Other Creditors": The "other creditors" line item has grown to over £1.1 million. Management must diagnose exactly what this debt consists of. If it represents deferred income or client money, the risk profile is different than if it represents unsecured operational debt.
3. Asset Utilization Review: The company owns a freehold property worth £852k. If this property is underutilized, consider subletting portions to create a new, healthy revenue stream that can offset the operational losses.
4. Review Commission Pipelines: Since turnover represents "commissions earned" (as stated in the accounting policies), the board must review whether the drop in retained earnings is due to a structural drop in commission volumes or an increase in overheads. Stimulating the top-line revenue is critical to recovery.